Authors:
SCARABIN PY
ALHENCGELAS M
PLUBUREAU G
TAISNE P
AGHER R
AIACH M
Citation: Py. Scarabin et al., EFFECTS OF ORAL AND TRANSDERMAL ESTROGEN PROGESTERONE REGIMENS ON BLOOD-COAGULATION AND FIBRINOLYSIS IN POSTMENOPAUSAL WOMEN - A RANDOMIZEDCONTROLLED TRIAL/, Arteriosclerosis, thrombosis, and vascular biology, 17(11), 1997, pp. 3071-3078
Authors:
SCARABIN PY
ALHENCGELAS M
PLUBUREAU G
TAISNE P
AGHER R
AIACH M
Citation: Py. Scarabin et al., EFFECTS OF ORAL AND TRANSDERMAL ESTROGEN PROGESTERONE REPLACEMENT THERAPY ON BLOOD-COAGULATION AND FIBRINOLYSIS IN POSTMENOPAUSAL WOMEN/, Thrombosis and haemostasis, 1997, pp. 788-788
Authors:
SCARABIN PY
VISSAC AM
KIRZIN JM
BOURGEAT P
AMIRAL J
AGHER R
GUIZE L
Citation: Py. Scarabin et al., POPULATION CORRELATES OF COAGULATION-FACTOR-VII - IMPORTANCE OF AGE, SEX, AND MENOPAUSAL STATUS AS DETERMINANTS OF ACTIVATED FACTOR-VII, Arteriosclerosis, thrombosis, and vascular biology, 16(9), 1996, pp. 1170-1176
Authors:
SCARABIN PY
VISSAC AM
LAROSA E
BOURGEAT P
AMIRAL J
AGHER R
GUIZE L
Citation: Py. Scarabin et al., DETERMINANTS OF FACTOR-VII ACTIVITY AND ACTIVATION IN A HEALTHY POPULATION, Thrombosis and haemostasis, 73(6), 1995, pp. 1380-1380
Authors:
PLUBUREAU G
VISSAC AM
LAROSA E
BOURGEAT P
AMIRAL I
AGHER R
GUIZE L
SCARABIN PY
Citation: G. Plubureau et al., ASSOCIATION BETWEEN LOW-DOSE COMBINATION ORAL-CONTRACEPTIVES AND HEMOSTATIC VARIABLES - IMPORTANCE OF PROGESTOGENS, Thrombosis and haemostasis, 73(6), 1995, pp. 1385-1385
Authors:
SCARABIN PY
ALHENCGELAS M
PLUBUREAU G
TAISNE P
AGHER R
GUIZE L
AIACH M
Citation: Py. Scarabin et al., ASSOCIATION OF HORMONE REPLACEMENT THERAPY TO HEMOSTATIC VARIABLES INPOSTMENOPAUSAL WOMEN, Thrombosis and haemostasis, 73(6), 1995, pp. 1385-1385
Citation: L. Bara et al., EXPRESSION OF A PARENTAL HISTORY OF PREMATURE CHD ON FACTOR-VIIC FIBRINOGEN AND PAI1, Thrombosis and haemostasis, 69(6), 1993, pp. 1079-1079